Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2022 16:05 ET | Source: Liquidia Corporation

Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option

MORRISVILLE, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) today announced the closing of its previously announced underwritten public offering of...
April 12, 2022 21:38 ET | Source: Liquidia Corporation

Liquidia Announces Pricing of Public Offering of Common Stock

MORRISVLLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock...
April 12, 2022 16:17 ET | Source: Liquidia Corporation

Liquidia Announces Proposed Offering of Common Stock

MORRISVILLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced today that it has commenced an underwritten public offering of its common stock. All...
March 22, 2022 16:30 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., March 22, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for an aggregate of 2,000 shares of...
March 17, 2022 06:30 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate Update

- Received tentative FDA approval of YUTREPIA™ (treprostinil) inhalation powder - Expanded use of Treprostinil Injection to include subcutaneous administration - Preparing to launch YUTREPIA in...
March 10, 2022 07:00 ET | Source: Liquidia Corporation

Liquidia Corporation to Report Full Year 2021 Financial Results on Thursday, March 17, 2022

MORRISVILLE, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2021 financial results on Thursday, March 17, 2022. The...
February 23, 2022 06:30 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for an aggregate of 25,700 shares of...
January 07, 2022 09:02 ET | Source: Liquidia Corporation

Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40.0 Million

MORRISVILLE, N.C., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the closing of a debt facility on January 7, 2022, with Silicon Valley Bank (SVB) which...
January 03, 2022 16:52 ET | Source: Liquidia Corporation

Liquidia Corporation Announces Chief Executive Officer Transition

MORRISVILLE, N.C., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022...
December 29, 2021 06:45 ET | Source: Liquidia Corporation

Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman Litigation

MORRISVILLE, N.C., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that United Therapeutics Corporation (UTC) has filed a stipulation of partial judgment with...